Replies to post #1595 on Biotech Values

[rwwine]

I don’t think the management change per se will necessarily make GENR more attractive to a partner, but the IND filing and the clear commitment to proceed aggressively in AMD will get people’s attention

Do you believe that GENR management feels that they would like to have a partnership deal in place by the Annual meeting in May?

Regards